PCR assay for chromosome 1p deletion in small neuroblastoma samples. - ENSTA Paris - École nationale supérieure de techniques avancées Paris Access content directly
Journal Articles International Journal of Cancer Year : 1992

PCR assay for chromosome 1p deletion in small neuroblastoma samples.


Deletion of the short arm of chromosome 1 is among the most recurrent cytogenetic alterations found in neuroblastoma and has been associated with short survival. However, this prognostic information, which relies on time-consuming techniques, is not yet routinely exploited. In order to set up a reliable and simple routine test to determine 1p deletion in neuroblastoma, we have used the polymerase chain reaction to genotype neuroblastoma DNA at 2 loci containing a variable number of tandem repeats and located on the distal part of the short arm of chromosome 1. Agarose gel electrophoresis and ethidium bromide staining of the amplification products enable a simple determination of constitutional and tumor genotypes at these loci to be made. A total of 37 samples from 29 patients were studied with this technique. Loss of heterozygosity (LOH) could be identified in 8 cases. In each case the results obtained were in agreement with those achieved by the Southern procedure. This technique will be of particular interest in the pretherapeutic analysis of 1p deletions in small tumor samples obtained by fine-needle aspirates of the primary tumor. It should also enable retrospective studies from paraffin-embedded tumor fragments to be made and provide information for the analysis of tumor heterogeneity in neuroblastoma and in other tumors with 1p deletions.
Not file

Dates and versions

hal-01160687 , version 1 (06-06-2015)


  • HAL Id : hal-01160687 , version 1
  • PUBMED : 1399134


M Peter, J Michon, P Vielh, S Neuenschwander, Y Nakamura, et al.. PCR assay for chromosome 1p deletion in small neuroblastoma samples.. International Journal of Cancer, 1992, 52 (4), pp.544-8. ⟨hal-01160687⟩
204 View
0 Download



Gmail Facebook Twitter LinkedIn More